Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 21 3051-3059, 2003
J Clin Oncol 21 3051-3059, 2003